Manama: The National Health Regulatory Authority (NHRA) has announced the withdrawal and suspension of registration of the pharmaceutical product “PROTON 40mg E.C TABLET – PROTON 20mg E.C TABLET”, produced by the Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO). The move is based on the warning issued by the Saudi Food and Drug Authority (SFDA) on March 12, 2021. The NHRA indicated said that it has withdrawn the medicine from the Kingdom, and suspended its registration because it does not match the original product. The NHRA recommended the health authorities to withdraw the product as soon as it is available to them, calling on the medicine users to contact their doctors to receive the alternative medication.
Trending
- Interior Minister chairs “Year of Isa Al Kabeer” committee meeting
- Education Minister meets Saudi counterpart in Riyadh
- Interior Minister chairs Civil Defence Council meeting
- HRH the Crown Prince and Prime Minister condoles with the Custodian of the Two Holy Mosques
- WHO urges governments to unlock health taxes on sugary drinks, alcohol to protect public health
- ISB Platinum Jubilee Cultural Fair Begins Thursday
- GCC Sec Gen participates in 5th Ministerial Roundtable of Future Minerals Forum
- SCIA holds 33rd regular meeting of the fifth term
